• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

BMS299897 Inhibitor – BMS 299897

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754624

BMS 299897 is a sulfonamide gamma-secretase inhibitor. It has an IC50 of 7nM for Abeta production inhibition in HEK293 cells stably overexpressing amyloid precursor protein (APP). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
BMS 299897 (BMS299897), Inhibitor
Full Product Name
BMS 299897
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
511.94
Solubility
DMSO: 30mg/mL (58.60mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C24H21ClF3NO4S
SMILES
FC1=CC=C(F)C(N([C@@H](C2=C(CCCC(O)=O)C=C(F)C=C2)C)S(C3=CC=C(Cl)C=C3)(=O)=O)=C1
CAS Number
290315-45-6
Target & IC50
Abeta, in HEK293 cells: ic50 7nM

Product Categories/Family for BMS299897, inhibitor

Structure of BMS299897, inhibitor

BMS299897 Inhibitor – Cat# MBS5754624

Product References and Citations for BMS299897, inhibitor

Meunier J, et al. The gamma-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Abeta1-42 seeding and short-term memory deficits in the Abeta25-35 mouse model of Alzheimer's d
Meunier J, et al. The gamma-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Abeta1-42 seeding and short-term memory deficits in the Abeta25-35 mouse model of Alzheimer's d
Weissmiller AM, et al. A gamma-secretase inhibitor, but not a gamma-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. PLoS One. 2015 Feb 24;10(2):e0118379.
Weissmiller AM, et al. A gamma-secretase inhibitor, but not a gamma-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. PLoS One. 2015 Feb 24;10(2):e0118379.

Other Notes

Small volumes of BMS299897, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BMS299897 purchase

MBS5754624 is an inhibitor targeting BMS299897. Also known as BMS 299897.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000